@article {3617, title = {Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease.}, journal = {Exp Ther Med}, volume = {8}, year = {2014}, month = {2014 Dec}, pages = {1906-1908}, abstract = {

It has previously been demonstrated that the circulating levels of TNF-related apoptosis-inducing ligand (TRAIL) are significantly lower in patients with type 1 diabetes (T1D) than in normal age- and gender-matched controls. Since celiac disease (CD) is often associated with T1D, a retrospective study was performed to analyze the sera of a cohort of pediatric subjects: i) patients with CD at onset (n=100); ii) patients with potential CD (n=45); iii) patients with CD associated with other auto-immune diseases (n=17); and iv) patients with eosinophilic esophagitis (n=15). Among the patients with CD, 49 were also analyzed after six months on a gluten-free diet, while data were also available for 13 patients after one year on a gluten-free diet. No significant differences were found in the circulating levels of TRAIL between the patients with CD and the patients with either eosinophilic esophagitis or potential CD. Patients with CD associated with other auto-immune diseases showed significantly lower levels of TRAIL when compared with patients with CD alone. The gluten-free diet did not significantly modify the levels of circulating TRAIL at 6 or 12 months. Thus, although T1D and CD share common immunological features, the circulating levels of TRAIL show a significant difference between the two pathologies, and do not appear to be modulated in CD.

}, issn = {1792-0981}, doi = {10.3892/etm.2014.2026}, author = {Celeghini, Claudio and Not, Tarcisio and Norcio, Alessia and Monasta, Lorenzo and Secchiero, Paola} } @article {1981, title = {Presence of CTAK/CCL27, MCP-3/CCL7 and LIF in human colostrum and breast milk.}, journal = {Cytokine}, volume = {61}, year = {2013}, month = {2013 Jan}, pages = {26-8}, abstract = {

Human colostrum and breast milk are known to contain high levels of cytokines and chemokines, which are thought to contribute to the development of the newborn. The aim of this study was to investigate the difference in the presence and levels of 21 soluble cytokines and chemokines in paired samples of human colostrum (day 2 after delivery) and breast milk (day 4-5 after delivery) by using the multiplex technology. Of the 21 cytokine investigated in 10 pairs of samples, only β-NGF was absent in both colostrum and milk, while INF-α2, SCF and TNF-β were present in colostrum but not in human milk. As a general rule, colostrum contained higher concentrations of cytokines and chemokines with respect to breast milk. The majority of cytokines, detected in colostrum alone or in colostrum and human milk (IL-1α, IL-2Rα, IL-3, IL-16, IL-18, GRO-α, HGF, IFN-α2, M-CSF, MIF, MIG, TNF-β, SDF-1α, TRAIL) have been described in previous studies, while for the first time we describe the presence of additional cytokines either in colostrum alone (SCF) or in both colostrum and breast milk (CTAK/CCL27, MCP-3/CCL7, LIF). Our data confirm and expand previous studies showing that some cytokines/chemokines, which might contribute to the development of the gastro-intestinal and nervous systems, are overexpressed in human colostrum and breast milk, and might contribute to the development of these systems.

}, keywords = {Adult, Chemokine CCL27, Chemokine CCL7, Chemokines, Colostrum, Cytokines, Female, Humans, Infant, Newborn, Leukemia Inhibitory Factor, Milk, Human}, issn = {1096-0023}, doi = {10.1016/j.cyto.2012.09.001}, author = {Radillo, Oriano and Norcio, Alessia and Addobbati, Riccardo and Zauli, Giorgio} } @article {1892, title = {MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.}, journal = {Br J Haematol}, volume = {157}, year = {2012}, month = {2012 May}, pages = {510-4}, keywords = {Antineoplastic Agents, Benzenesulfonates, Cell Line, Tumor, Down-Regulation, Humans, Leukemia, Myeloid, Acute, Myeloid Cell Leukemia Sequence 1 Protein, Niacinamide, Phenylurea Compounds, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-bcl-2, Pyridines, Pyrimidines, Thiazoles}, issn = {1365-2141}, doi = {10.1111/j.1365-2141.2012.09042.x}, author = {Secchiero, Paola and Melloni, Elisabetta and Voltan, Rebecca and Norcio, Alessia and Celeghini, Claudio and Zauli, Giorgio} } @article {1932, title = {Potential role of TRAIL in the management of autoimmune diabetes mellitus.}, journal = {Curr Pharm Des}, volume = {18}, year = {2012}, month = {2012}, pages = {5759-65}, abstract = {

Type 1 diabetes mellitus (T1DM) is an autoimmune disease, due to the immune-mediated destruction of pancreatic β-cells, whose incidence has been steadily increasing during the last decades. Insulin replacement therapy can treat T1DM, which, however, is still associated with substantial morbidity and mortality. For this reason, great effort is being put into developing strategies that could eventually prevent and/or cure this disease. These strategies are mainly focused on blocking the immune system from attacking β-cells together with functional islet restoration either by regeneration or transplantation. Recent experimental evidences suggest that TNFrelated apoptosis-inducing ligand (TRAIL), which is an immune system modulator protein, could represent an interesting candidate for the cure for T1DM and/or its complications. Here we review the evidences on the potential role of TRAIL in the management of T1DM.

}, keywords = {Animals, Autoimmunity, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin-Secreting Cells, Islets of Langerhans, TNF-Related Apoptosis-Inducing Ligand}, issn = {1873-4286}, author = {Bernardi, Stella and Norcio, Alessia and Toffoli, Barbara and Zauli, Giorgio and Secchiero, Paola} } @article {1903, title = {SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155.}, journal = {Invest New Drugs}, volume = {30}, year = {2012}, month = {2012 Dec}, pages = {2403-6}, abstract = {

The basal SOCS1 mRNA levels were significantly lower in p53(mutated) BJAB and MAVER leukemic cell lines with respect to p53(wild-type) SKW6.4 and JVM-2 leukemic cell lines, p53(wild-type) primary B chronic lymphocytic leukemia (B-CLL) cells and primary normal peripheral blood mononuclear cells (PBMC). Moreover, the MDM2 small molecule inhibitor Nutlin-3 significantly increased the levels of SOCS1 mRNA in both primary p53(wild-type) B-CLL cells as well as in p53(wild-type) B leukemic cell lines, but not in p53(mutated) B leukemic cell lines nor in primary PBMC. Of note, a significant inverse correlation was observed between SOCS1 mRNA and miR-155 levels in Nutlin-3-treated primary B-CLL cells and PBMC, suggesting that the miRNA-155/SOCS1 axis represents a potentially important therapeutic target of Nutlin-3 in B-CLL.

}, keywords = {Cell Line, Tumor, Cells, Cultured, Down-Regulation, Humans, Imidazoles, Leukemia, Lymphocytic, Chronic, B-Cell, Leukocytes, Mononuclear, MicroRNAs, Piperazines, Suppressor of Cytokine Signaling Proteins, Tumor Suppressor Protein p53, Up-Regulation}, issn = {1573-0646}, doi = {10.1007/s10637-011-9786-2}, author = {di Iasio, Maria Grazia and Norcio, Alessia and Melloni, Elisabetta and Zauli, Giorgio} }